Cepheid Achieves CE Marking Under IVDR for Xpert® Respiratory Panel
IVDR-compliant PCR test detects 13 common respiratory pathogens from a single sample. SUNNYVALE, Calif., Nov. 10, 2026 /PRNewswire/ -- Cepheid, a Danaher company, announced today that it has achieved CE marking under the in vitro medical device regulation (IVDR) for the Xpert Respiratory...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 129 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.